Universite de Montpellier
Records under this name other than the patents Universite de Montpellier holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 211 patents it holds.
Back to Universite de Montpellier
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,608,600 | Modified 2' and 3'-Nucleoside Prodrugs for Treating Flaviviridae Infections now held by Idenix Pharmaceuticals LLC In force · Medium confidence | In force | Medium confidence | |
| US 8,536,318 | Chemical RNA Synthesis Method now held by Chemgenes Corporation In force · High confidence | In force | High confidence | |
| US 9,611,481 | Novel Chimeric Polynucleotides and Polypeptides Enabling the Secretion of a Polypeptide of Interest in Combination with Exosomes and Uses Thereof now held by Ciloa S.A.S. In force · High confidence | In force | High confidence | |
| US 9,012,607 | Novel Mutated Humanized 12G4 Antibodies and the Fragments Thereof Against the Human Anti-Mullerian Hormone Receptor Type II now held by Icm Institut Regional du Cancer de Montpellier In force · High confidence | In force | High confidence | |
| US 9,511,138 | Novel Pharmaceutical Compositions Comprising an Antibody Which Binds the Human Anti-Mullerian Hormone Receptor Type II now held by Icm Institut Regional du Cancer de Montpellier In force · High confidence | In force | High confidence | |
| US 9,637,544 | Novel Mutated Humanized 12G4 Antibodies and the Fragments Thereof Against the Human Anti-Mullerian Hormone Receptor Type II now held by Icm Institut Regional du Cancer de Montpellier In force · High confidence | In force | High confidence | |
| US 10,179,816 | Novel Pharmaceutical Compositions Comprising an Antibody Which Binds the Human Anti-M¿llerian Hormone Receptor Type I now held by Icm Institut Regional du Cancer de Montpellier In force · High confidence | In force | High confidence | |
| US 9,376,468 | Cell Penetrating Peptides for Intracellular Delivery of Molecules now held by Aadigen, LLC In force · High confidence | In force | High confidence | |
| US 9,546,371 | Chimeric Polynucleotides and Polypeptides Enabling Secretion of a Polypeptide of Interest in Association with Exosomes and Use Thereof for the Production of Immunogenic Compositions now held by Ciloa S.A.S. In force · Medium confidence | In force | Medium confidence | |
| US 9,127,065 | Anti-Human HER3 Antibodies and Uses Thereof now held by University of Montpellier In force · High confidence | In force | High confidence |